Sign in

CIK 0001677077 · <br>Emerging growth company

Alzamend Neuro, Inc.

Sign in to watch
Ticker
ALZN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Apr 30
Incorporated
DE
Entity type
operating
EIN
811822909
Phone
844-722-6333
Business address
480 PEACHTREE ROAD NE, SECOND FLOOR, SUITE 103, ATLANTA, GA, 30326
  1. 8-K Event Unregistered share sale
  2. 4 Open-market sale Director sold 139,412 shares at an average $2.47 ($344,222)
  3. SCHEDULE 13D/A Stake Beneficial Ownership Report
  4. SCHEDULE 13D/A Stake Beneficial Ownership Report
  5. 4 Open-market sale Director sold 123,366 shares at an average $2.41 ($296,789)
  6. SCHEDULE 13D/A Stake Beneficial Ownership Report
  7. 4 Open-market sale Director sold 79,628 shares at an average $2.31 ($184,156)
  8. SCHEDULE 13D/A Stake Beneficial Ownership Report
  9. 4 Open-market sale Director sold 97,006 shares at an average $2.34 ($226,923)
  10. 8-K Event Unregistered share sale
  11. SCHEDULE 13D/A Stake Beneficial Ownership Report
  12. 4 Open-market sale Director sold 77,009 shares at $2.35 ($180,856)
  13. 4 Open-market sale Director sold 22,991 shares at an average $2.47 ($56,696)
  14. 10-Q Report Quarterly Report
  15. SCHEDULE 13D/A Stake Beneficial Ownership Report
  16. 8-K Event Unregistered share sale
  17. 4 Open-market sale Director sold 129,449 shares at an average $2.28 ($295,532)
  18. 4 Open-market sale Director sold 44,843 shares at an average $2.86 ($128,169)
  19. 4 Open-market sale Director sold 69,137 shares at an average $2.95 ($203,821)
  20. 8-K Event Results of operations

Page 3 of 20 · 398 filings